new technologies competing with glp-1 medications 2025 trends 2025: real-world data, patient outcomes & future therapies GLP-1 Receptor Agonist Market Size

Heart Health: See how Wegovy reduced cardiovascular events in the landmark SELECT trial and what that means for Connecticut patients: Wegovy & Heart Protection

This is really important for people with type 2 diabetes or obesity, who are more likely to feel depressed

[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Klonoff DC, Buse JB, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, Wintle ME, Maggs DG

GLP-1 Weight Loss in Laurel, MD, Alexandria, VA and Washington D.C

Market consolidation is evident

Among our coverage of peer-reviewed research and preliminary findings this week, a few studies and reviews have particularly stood out